Led · Equity · May 2025

Metafoodx provides a patented, AI-powered food operations platform that uses a 3D AI scanner to capture an item’s image, weight and temperature, link it to menus, and automatically log items for food-safety compliance. Its platform is used by universities and food service providers and is designed to reduce food waste and optimize production through real-time data and automation. The company says deployments deliver up to a 50% reduction in food waste and a 200% ROI within weeks. Metafoodx earned a 2025 Kitchen Innovations Award from the National Restaurant Association for its AI use case. Led by CEO Fengmin Gong, the company intends to use the new funds to expand operations and advance development efforts. Metafoodx is based in San Jose, CA.

Participated · Series C · Sep 2024

Cherre provides a data management and intelligence platform for the real estate industry, giving clients control over moving and managing their data while offering visibility, observability, and validation tools. The platform increases transparency into data pipelines, transforms data for interoperability, enables observability and validation across the data value chain, and supports remediation to improve downstream data quality. Cherre’s product is used for analysis, reporting, modeling, app development, and decision-making, and it partners with large data providers, applications, and service providers to create an ecosystem that supports client data needs. The company plans to invest the new capital to expand its data intelligence and insight capabilities and accelerate development of cutting-edge data management and intelligence tools. After a year of double-digit revenue growth, Cherre says the funding will allow it to scale, improve process intelligence, and help clients build a composable target operating model for competitive advantage. Cherre provides a real estate data and insight platform that aggregates property and market information for enterprise decision makers. Led by CEO and co-founder L.D. Salmanson, the company serves customers across technology, asset management, commercial brokerage and P&C insurance. In 2020 Cherre signed global enterprise customers across those sectors. The company plans to use recent funding to expand platform offerings, introduce and integrate additional partner data sets and applications, launch a customer advisory board, and grow the team. The articles note a $50M growth funding raise, reflecting an active growth-stage capital position. No revenue or user metrics were disclosed in the coverage. Cherre provides an AI-enabled real estate data and analytics SaaS platform that collects, augments, resolves, and analyzes datasets from hundreds of thousands of public, private, and internal sources. Its knowledge graph contains granular, actionable information on over 177 million properties, 84 million companies, 315K datasets and billions of connected data points. The platform supports high-performance, low-latency API delivery as well as a transactional database to meet demanding enterprise use cases. Customers include large enterprises, insurance companies, banks, and investors; common applications cited are automated P&C insurance underwriting, desk inspections, lending pre-fill, and AI decision-support for investment and underwriting. Cherre launched in 2016 and commercially launched in August 2018; it has raised $25 million in total capital to date following the latest growth round. Intel Capital said the platform is a foundational data system of record and that it will help accelerate Cherre’s global growth trajectory; the company has also established a growth-debt relationship with Silicon Valley Bank to support expansion. Cherre provides large enterprises, insurance companies, banks and investors with a platform to collect, augment and resolve property data in real time from thousands of public, private and internal sources. The platform supplies up-to-date information such as property history, demographics and market comparisons to support advanced analytics and decision-making. Cherre was founded in 2016 and is led by CEO L.D. Salmanson, and is based in New York City. The company raised $9M in a seed funding round led by Navitas Capital, with participation from Carthona Capital, iLOOKABOUT, Dreamit Ventures and Red Swan Ventures. Cherre intends to use the funds to bring its streamlined real estate data services to more clients and to expand operations throughout the U.S. and Canada. Clients include The Real Estate Board of NY (REBNY), Keller Williams NYC, Stratus Data Systems, August Partners, Platinum Properties and various other Fortune 500 companies.

Participated · Series B · Feb 2024

Heqirui Pharmaceutical is a science-driven clinical-stage innovative biopharmaceutical company with R&D bases and offices in Beijing, Shanghai and Nanjing. The company was founded on translational research led by Professor Xiao Ruiping and his team at Peking University's Future Technology Institute. Heqirui focuses on women's health, endocrine and cardiovascular disease areas and is building a diversified pipeline to address unmet clinical needs. Its development model combines in-house R&D with patent in-licensing. The core pipeline includes HMI-115, a monoclonal antibody currently conducting two international Phase II clinical studies. The company recently completed a nearly RMB 200 million B+ financing to support HMI-115's international trials and continued development of other product lines. Hope Medicine Inc. (HopeMed) is a global, science-driven innovative biopharmaceutical company founded by Professor Rui‑Ping Xiao with R&D bases and offices in Nanjing, Shanghai, and Beijing. The company focuses on first-in-class drugs in women's health, endocrinology, and cardiovascular areas through independent R&D and license‑in models. Its pipeline includes HMI‑115, a prolactin receptor antibody in-licensed from Bayer for androgenic alopecia and endometriosis; HMI‑115 completed Phase I trials in the EU with positive safety results. HopeMed plans to launch global multi-center Phase II (MRCT) trials for androgenic alopecia and endometriosis and to advance commercial product development. The company emphasizes building an international multidisciplinary team and strengthening global intellectual property to address unmet medical needs. HopeMed completed a significant Series B financing to support its upcoming international clinical studies and further development of its pipeline.

Participated · Series B · Jan 2023

Hystar develops advanced PEM electrolyser systems for large-scale green hydrogen production, offering containerized units in 1–5 MW sizes and modular designs that can scale to plants up to 1 GW. Its product portfolio includes Vega™ and Mira™ electrolyser lines, with Orion comprising constellations of Vega, Mira, or combinations for larger deployments. The systems use the company’s patented PEM technology concepts aimed at making green hydrogen production more accessible across applications. Hystar plans to use the new capital to scale up commercial operations and enter new markets. The company is led by CEO Fredrik Mowill and is headquartered in Oslo, Norway. Financially, Hystar completed a $26M Series B to support its commercialization efforts.

Led · Equity · Feb 2022

G7 is an IoT solutions provider serving the traditional road freight industry. The company is based in China. G7 secured an aggregate of $200 million in a new funding round. The round was jointly led by private equity firm Trustbridge Partners and state-backed CS Capital. The article lists those two investors and does not disclose additional participants, operating metrics, valuation, or use of proceeds. No financing instruments or past rounds were specified in the article. G7 runs a proprietary connected platform that links trucks, shippers, fleet managers and drivers to streamline logistics operations. The company says it reaches 60,000 customers and 800,000 commercial vehicles worldwide, and counts 85% of China’s largest logistics providers as clients. It has partnered with industry players such as NIO and Total Energy Ventures to build out connected trucking and energy-related networks. G7 positions artificial intelligence in IoT, intelligent equipment and asset-as-a-service as key areas for future development. The company is eight years old and is using the latest funding to drive technological development across its platform.